Trial site
Hangzhou
- 24running trials
- 19closed trials
The trials here
What the 43 trials at this site are about, from their registry records.
- Conditions
- Chronic myeloid leukaemia4 trials
- Coronary artery disease4 trials
- Familial hypercholesterolaemia4 trials
- Lung cancer4 trials
- Chronic spontaneous urticaria3 trials
- IgA nephropathy3 trials
- Metastatic breast cancer3 trials
- Multiple sclerosis3 trials
- Stroke3 trials
- Immune thrombocytopenia (ITP)2 trials
- Myeloproliferative neoplasms2 trials
- Prostate cancer2 trials
- and 15 more
- Phase
- Phase 327 trials
- Phase 28 trials
- Phase 45 trials
- Status
- Active, not recruiting18 trials
- Completed16 trials
- Recruiting6 trials
- Terminated3 trials
- Lead sponsor
- Novartis Pharmaceuticals43 trials
Running trials
Recruiting
Recruiting
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
Recruiting
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Active, not recruiting
Inclisiran Effectiveness in China: a Pragmatic Randomized Trial
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CP
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Atopic dermatitis (eczema)1 recruiting
- Hidradenitis suppurativa1 recruiting
- IgA nephropathy1 recruiting
- Multiple sclerosis1 recruiting
- Myeloproliferative neoplasms1 recruiting
- Prostate cancer1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Study of Efficacy and Safety of Ofatumumab in Relapsing Multiple Sclerosis (RMS) Patients in China
Terminated
Completed
Completed
Completed
Completed
Completed
Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients
Completed
Terminated
Terminated
Completed
Completed
Completed
Study of Efficacy and Safety of Erenumab in Adult Chronic Migraine Patients
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026